The cliff was never the crisis: Pharma’s strategy problem
The patent cliff isn't the problem. It's the symptom.
Newsletters and Deep Dive digital magazine
The patent cliff isn't the problem. It's the symptom.
The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for millions of patients.
AstraZeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new $1.77bn agreement to develop drugs for kidney diseases.
Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.
The digital, supplier, CRO, and medtech services sectors continued to see a steady flow of leadership changes during the month of May.
Editor's Picks
Newsletters and Deep Dive
digital magazine